# Early Phase Clinical Research Support

> **NIH NIH P30** · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 2020 · $192,485

## Abstract

EARLY PHASE CLINICAL RESEARCH SUPPORT (EPCRS) 
ABSTRACT 
The overall objective of the Early Phase Clinical Research Support (EPCRS) is to promote, support and 
execute the conduct of high priority UAB Cancer Center investigator initiated early (Phase I / Pilot) clinical 
trials. This support extends to trials involving novel agents, innovative concepts or proof of concept translation 
of successful laboratory investigation. Cancer Center study support includes input on study design (see 
Translational Concept Meeting), scientific review (see PRMS); as well as research nursing and data 
management support for the conduct of the clinical trial (see CPDM). The CCSG institutional support for early 
phase investigator initiated clinical trials represents an invaluable mechanism for the support of high priority, 
proof of concept or translational research efforts with the aim to generate preliminary data that would serve as 
the basis for future competitive funding for later phase studies 
Access to EPCRS is reserved for investigator initiated trials that score well at the Protocol Review Committee 
(Score <4) and have limited or no funding. During the current cycle seventeen trials were eligible and received 
varying levels of support dependent upon financial need and priority. These trials accrued 218 patients since 
2011. 
The Specific Aims of the Early Phase Clinical Trial Support are: 
1. To promote the design of early phase innovative proof of concept and/or translational research trials 
 initiated by Cancer Center Faculty 
2. To provide research nursing/data management support, and administrative oversight for such high 
 priority investigator initiated clinical trials that lack adequate extramural funding 
3. To support the overall successful conduct of such early phase investigator initiated clinical trials

## Key facts

- **NIH application ID:** 9895658
- **Project number:** 5P30CA013148-48
- **Recipient organization:** UNIVERSITY OF ALABAMA AT BIRMINGHAM
- **Principal Investigator:** MANSOOR N SALEH
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $192,485
- **Award type:** 5
- **Project period:** — → 2022-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9895658

## Citation

> US National Institutes of Health, RePORTER application 9895658, Early Phase Clinical Research Support (5P30CA013148-48). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9895658. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
